1Hak AE,Pols HAP,Visser TJ,et al.Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women:The Rotterdam Study[J].Ann Int Med,2000,132:270-278.
2Mya MM,Aronow WS.Subclinical hypothyroidism is associated with coronary artery disease in older persons[J].J Gerontol A Biol Sci Med Sci,2002,57:658-659.
3Cappola AR,Ladenson PW.Hypothyroidism and atherosclerosis[J].J Clin Endocrinol Metab,2003,88:2438-2444.
4Caraccio N,Ferrannini E,Monzani F.Lipoprotein profile in subclinical hypothyroidism:effect of levothyroxine replacement therapy-a randomized,placebo-controlled study[J].J Clin Endocrinol Metab,2002,87:1533-1538.
8Christ-Crain M,Meier C,Guglielmetti M,et al.Elevated C-reactive protein and homocysteine values:cardiovascular risk factors in hypothyroidism?A cross-sectional and a double-blind,placebo-controlled trial[J].Atherosclerosis,2003,166:379-386.
9Kvetny J,Heldgaard PE,Bladbjerg EM.Subclinical hypothyroidism is associated with a low-grade inflammation,increased triglyceride levels and predicts cardiovascular disease in males below 50 years[J].Clin Endocrinol(Oxf),2004,61(2):232-238.
10Jublanc C,Bruckert E,Giral P,et al.Relationship of circulating C-reactive protein levels to thyroid status and cardiovascular risk in hyperlipidemic euthyroid subjects:low free thyroxine is associated with elevated hsCRP[J].Atherosclerosis,2004,172(1):7-11.
2Devaraj S, Xu DY, Jialal I. C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells:implications for the metabolic syndrome and atherothrombosis. Circulation ,2003,107 ( 3 ) :398-404.
3Portik-Dobos V, Anstadt MP, Hutchinson J, et al. Evidence for a matrix metalloproteinase induction/activation system in arterial vascularture and decreased synthesis and activity in diabetes. Diabetes,2002,51 (10) :3036-3068.
4Haffner SM, Greenberg AS, Weston WM, et al. Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus. Circulation, 2002, 106(6) :679-684.
5Ross R. Atherosclerosis is an inflammatory disease. Am Heart J,1999,138(5 pt 2) :S419-420.
6Brand K, Page S, Kogler G, et al. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest, 1996,97 ( 7 ): 1715-1722.
7Erbagci AB,Tarakcioglu M, Coskun Y,et al. Mediators of inflammation in children with type Ⅰ diabetes mellitus: cytokines in type Ⅰ diabetic children. Clin Biochem,2001,34 ( 8 ) :645-650.
8Temaru R, Urakaze M, Satou A, et al. High glucose enhances the gene expression of interleukin-8 in human endothelial cells, but not in smooth muscle cells: possible role of interleukin-8 in diabetic macroangiopathy. Diabetologia, 1997,40( 5 ) :610-613.
9Pasceri V, Cheng JS, Willerson JT, et al. Modulation of C-reactioe protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation,2001,103(21 ) :2531-2534.
10Verma S, Kuliszewski MA, Li SH, et al. C-reactioe protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between CRP and cardiovascular disease. Circulation,2004,109 ( 17 ) :2058-2067.
